The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so if a woman is taking estriol which she's probably taking in a topical fashion in combination with um estral that they usually refer to that as a bi EST you'll hear that abbreviated biest which just means by estrogen so they'll combine in some fraction anywhere from 5050 to 802 estra diol with estriol and a woman will apply that topically but again that's not FDA approved that is something that compounding pharmacies would have to make for a physician
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.